The controversial new clinical trials that promise faster results
20 October 2021
Standard clinical trials used to test new medicines are slow and cumbersome. The pandemic has shown that a new kind of trial is far quicker, but is it reliable enough?
-
Subject
-
Section
-
Type
-
Topics
-
Author
-
Issue
-
Premium
The science of cannabis: Can it really help our mental health?
2 December 2019
Cannabis was long thought to harm mental health but is now prescribed as a treatment. Psychopharmacologist Val Curran looks at the evidence
How we're using CRISPR to fight cancer
2 December 2019
Molecular biologist Fiona Behan reports on how the CRISPR gene-editing technique can find cancer’s weak points, identifying targets for new drugs
Half-hearted cannabis legalisation move leaves patients in limbo
16 October 2018
Medical cannabis is to be available in the UK from November, but tight restrictions will drive patients to alternative sources, says Henry Fisher
Medical cannabis: What you really need to know
18 July 2018
The UK looks set to become the latest place to legalise medical cannabis. But with its use sweeping the world, many questions remain about what it does and how
First cannabis-based drug approved in the US to treat epilepsy
26 June 2018
Epidiolex has become the first drug derived from marijuana to win FDA approval in the US, and will be used to treat two forms of childhood epilepsy
Time to end the cruel ban on using cannabis therapy for epilepsy
19 June 2018
Ill-conceived and outdated drug laws in the UK are denying children with severe epilepsy vital medicinal cannabis treatments. That must change, says David Nutt
Opioids that hit different brain target could be less addictive
4 January 2018
Researchers have determined how morphine derivatives bind to the kappa opioid receptor, which should enable safer painkillers to be developed
Psychedelic medicine: the potential, the people, the politics
18 August 2017
Doing science with psychedelics has unique challenges, but the rewards could be mind-blowing. New Scientist looks at the state of play as things begin to ramp up
